Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Exercise Tolerance in Fontan Patients
NCT00507819Phase 2Completed
- Sponsor
- Children's Hospital of Philadelphia
- Start
- Dec 2007
- Primary completion
- Apr 2009
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of ASP-001 in hypoplastic left heart syndrome (HLHS) and tricuspid atresia (2 arms), sponsored by Children's Hospital of Philadelphia. Primary endpoint: Mean Oxygen Consumption at 6 weeks. Started Dec 2007; status: completed.
02
Drugs
ASP-001
03
Conditions
hypoplastic left heart syndrome (HLHS)tricuspid atresia
Beyond the preview
Go deeper on NCT00507819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00507819.